– GERMANY, Berlin – MagForce AG (Frankfurt, Xetra: MF6), a leading medical device company in the area of nanotechnology with a focus on oncology, today announced details on the change in the Company’s Supervisory Board. Dr Jan zur Hausen stepped back from his membership position on September 13, 2013, due to personal reasons. The county court Berlin-Charlottenburg appointed Stephan Jakober as new Supervisory Board member.
Stephan Jakober is Chief Financial Officer of Film House Germany AG, a Berlin-based production company for international and German movies, and works as consultant vor CIB Beratung AG (Zurich) in the area of Private Equity, Corporate Finance and Mergers & Acquisition. Prior to that, Stephan Jakober was reponsible for investments in medium-sized enterprises for different European Private Equity Funds as Investment Director.
Stephan Jakober studied Business Administration at the University of St Gallen (HSG).
About MagForce AG
MagForce AG is a leading medical device company in the field of nanomedicine in oncology, listed in the entry standard (MF6). The Company’s proprietary, NanoTherm® therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator® are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm®, NanoPlan®, and NanoActivator® are trademarks of MagForce AG in selected countries.
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.